Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The update history now includes May 2026 entries (2026-05-08, 2026-05-07, 2026-05), while April 2026 entries (2026-04-22, 2026-04-09, 2026-04) were removed. These entries document when the page was updated, not changes to the study content.
    Difference
    0.1%
    Check dated 2026-05-12T20:51:56.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Two new Chinese study sites were added: Hunan Cancer Hospital Chest Tumor Internal Medicine dept. II in Changsha and Beijing Cancer Hospital Chest Tumor Internal Medicine dept. II in Beijing, bringing total locations to 249 and updating the record to revision v3.5.3.
    Difference
    0.2%
    Check dated 2026-04-28T08:04:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-21T01:34:49.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-23T03:12:13.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed, indicating a software version update with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-03-08T23:41:36.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The change is a revision update from v3.4.1 to v3.4.2 with no impact on study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:02:27.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.